While based on the energy balance physiology, detailed above, there is a strong rationale for leptin analogues in obesity treatment, metreleptin failed to achieve clinically meaningful weight loss with a mean of just 1.5 kg lost over 24 weeks [223]. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.